E-Cigs plus coaching may help mentally ill smokers cut harm

NCT ID NCT06543407

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether giving e-cigarettes to smokers with mental illness—along with optional behavioral coaching—helps them switch from regular cigarettes and lower their exposure to harmful chemicals. The trial enrolls 250 daily smokers who have tried to quit before but aren't ready to quit now. Participants either get e-cigarettes alone or e-cigarettes plus up to 10 coaching sessions over 8 weeks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
e-cigarettes (NJOY brand) and behavioral support (SWITCH IT coaching)
What this could lead to
If it works, this could offer a practical way for smokers with mental illness who can't quit to reduce their health risks by switching to e-cigarettes.
What could go wrong
This is an early-stage study with 250 participants, so results may not apply to everyone. E-cigarettes are not risk-free, and long-term effects are still unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANXIETY DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Seven Counties Services

    RECRUITING

    Louisville, Kentucky, 40203, United States

    Contact Email: •••••@•••••

    Contact Email: •••••@•••••

  • The Providence Center

    RECRUITING

    Providence, Rhode Island, 02903, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.